Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
ImClone Systems Incorporated is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. The Company’s research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone Systems’ strategy is to become a fully integrated biopharmaceutical company, taking its development programs from the research stage to the market. ImClone Systems’ headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New ( www.imclone.com )
ImClone Systems Inc.
180 Varick Street
New York, New York 10014
USA
Tel: (212) 645-1405
Fax: (212) 645-2054